| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.073 | 0.04 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.11 | 0.04 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.04 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.04 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.05 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | 0.07 | 0.05 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.05 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.072 | 0.05 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.05 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.07 | 0.06 |